Clinical Trial of Chidamide Combined With CHOP in Peripheral T-cell Lymphoma Patients

Clinical trial NCT02809573 · COMPLETED

Trial details

NCT number: NCT02809573
Sponsor: Chipscreen Biosciences, Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Peripheral T-cell Lymphoma

Start date: 2016-08-11
Primary completion: 2019-01-08
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.